ZA843270B - Photochemical decontamination treatment of whole blood or blood components - Google Patents
Photochemical decontamination treatment of whole blood or blood componentsInfo
- Publication number
- ZA843270B ZA843270B ZA843270A ZA843270A ZA843270B ZA 843270 B ZA843270 B ZA 843270B ZA 843270 A ZA843270 A ZA 843270A ZA 843270 A ZA843270 A ZA 843270A ZA 843270 B ZA843270 B ZA 843270B
- Authority
- ZA
- South Africa
- Prior art keywords
- blood
- decontamination treatment
- whole blood
- photochemical decontamination
- components
- Prior art date
Links
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 239000012503 blood component Substances 0.000 title 1
- 238000005202 decontamination Methods 0.000 title 1
- 230000003588 decontaminative effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- 230000001766 physiological effect Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical class C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
- A61L2/10—Ultra-violet radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
- A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Cardiology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Anesthesiology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49068183A | 1983-05-02 | 1983-05-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA843270B true ZA843270B (en) | 1984-11-28 |
Family
ID=23949050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA843270A ZA843270B (en) | 1983-05-02 | 1984-05-02 | Photochemical decontamination treatment of whole blood or blood components |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0124363B1 (fr) |
JP (1) | JPS6016930A (fr) |
AT (1) | ATE59145T1 (fr) |
AU (1) | AU563557B2 (fr) |
CA (1) | CA1224622A (fr) |
DE (1) | DE3483751D1 (fr) |
ZA (1) | ZA843270B (fr) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK507185A (da) * | 1984-11-05 | 1986-05-06 | Du Pont | Fremgangsmaade til inaktivering af human tumor leukaemi virus iii |
JPS61275228A (ja) * | 1985-03-14 | 1986-12-05 | バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド | 治療用タンパク組成物中のビ−ルスの光動的不活性化 |
US4789545A (en) * | 1986-03-31 | 1988-12-06 | New York Blood Center, Inc. | Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof |
US4775625A (en) * | 1986-11-21 | 1988-10-04 | The Medical College Of Wisconsin, Inc. | Inactivating enveloped viruses with a merocyanine dye |
US4878891A (en) † | 1987-06-25 | 1989-11-07 | Baylor Research Foundation | Method for eradicating infectious biological contaminants in body tissues |
US5571666A (en) * | 1988-10-28 | 1996-11-05 | Oklahoma Medical Research Foundation | Thiazine dyes used to inactivate HIV in biological fluids |
IL92996A (en) * | 1989-01-10 | 1996-06-18 | Bisaccia Emil | Photovoltaic compounds as drugs for the treatment of viral infections and a method for the production of vaccines |
AU649992B2 (en) * | 1989-10-26 | 1994-06-09 | George D. Cimino | Activation compounds and methods for nucleic acid sterilization |
US5503721A (en) | 1991-07-18 | 1996-04-02 | Hri Research, Inc. | Method for photoactivation |
WO1991016060A1 (fr) * | 1990-04-16 | 1991-10-31 | Cryopharm Corporation | Procede pour rendre inactifs des contaminants sanguins viraux et bacteriens |
US5418130A (en) | 1990-04-16 | 1995-05-23 | Cryopharm Corporation | Method of inactivation of viral and bacterial blood contaminants |
US6187572B1 (en) | 1990-04-16 | 2001-02-13 | Baxter International Inc. | Method of inactivation of viral and bacterial blood contaminants |
US5516629A (en) | 1990-04-16 | 1996-05-14 | Cryopharm Corporation | Photoinactivation of viral and bacterial blood contaminants using halogenated coumarins |
US5120649A (en) * | 1990-05-15 | 1992-06-09 | New York Blood Center, Inc. | Photodynamic inactivation of viruses in blood cell-containing compositions |
US5232844A (en) * | 1990-05-15 | 1993-08-03 | New York Blood Center | Photodynamic inactivation of viruses in cell-containing compositions |
US5981163A (en) * | 1990-05-15 | 1999-11-09 | New York Blood Center, Inc. | Process for the sterilization of biological compositions using irradiation and quenchers of type I and type II photodynamic reactions |
US5712086A (en) * | 1990-05-15 | 1998-01-27 | New York Blood Center, Inc. | Process for transfusing cell containing fractions sterilized with radiation and a quencher of type I and type II photodynamic reactions |
DE4136900C1 (fr) * | 1991-11-09 | 1993-07-29 | Schaper & Bruemmer Gmbh & Co Kg, 3320 Salzgitter, De | |
EP0633786B1 (fr) * | 1992-01-27 | 2001-08-01 | Baxter International Inc. | Procede d'inactivation des contaminants viraux, parasitaires et bacteriens du sang |
AU4677993A (en) * | 1992-08-07 | 1994-03-03 | Steritech, Inc. | Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen |
US5288605A (en) * | 1992-03-02 | 1994-02-22 | Steritech, Inc. | Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen |
US6420570B1 (en) | 1993-06-28 | 2002-07-16 | Cerus Corporation | Psoralen compounds |
US5556993A (en) | 1993-06-28 | 1996-09-17 | Steritech, Inc. | Compounds for the photodecontamination of pathogens in blood |
US5399719A (en) | 1993-06-28 | 1995-03-21 | Steritech, Inc. | Compounds for the photodecontamination of pathogens in blood |
US6319662B1 (en) | 1993-12-17 | 2001-11-20 | Baxter International Inc. | Method and apparatus for removing viral contaminants from a body fluid |
US7186543B1 (en) | 1998-07-21 | 2007-03-06 | Gambro Inc. | Preparation of vaccines using a photosensitizer and light |
US6258577B1 (en) | 1998-07-21 | 2001-07-10 | Gambro, Inc. | Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers |
US6268120B1 (en) | 1999-10-19 | 2001-07-31 | Gambro, Inc. | Isoalloxazine derivatives to neutralize biological contaminants |
US7985588B2 (en) | 2000-06-02 | 2011-07-26 | Caridianbct Biotechnologies, Llc | Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light |
US7648699B2 (en) | 2000-06-02 | 2010-01-19 | Caridianbct Biotechnologies, Llc | Preventing transfusion related complications in a recipient of a blood transfusion |
TW590780B (en) | 2000-06-02 | 2004-06-11 | Gambro Inc | Additive solutions containing riboflavin |
US9044523B2 (en) | 2000-06-15 | 2015-06-02 | Terumo Bct, Inc. | Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light |
AU2002366708A1 (en) * | 2001-12-20 | 2003-07-09 | Gambro, Inc. | Preparation of vaccines using photosensitizer and light |
NL2000281C2 (nl) | 2005-11-02 | 2007-08-07 | Pfizer Prod Inc | Vaste farmaceutische samenstellingen die pregabaline bevatten. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL6702923A (fr) * | 1966-04-06 | 1967-10-09 | ||
US4321919A (en) * | 1979-12-11 | 1982-03-30 | Leukocyte Research, Inc. | Method and system for externally treating human blood |
DE3033932C2 (de) * | 1980-09-10 | 1984-05-24 | Biotest-Serum-Institut Gmbh, 6000 Frankfurt | Verfahren zur Kaltsterilisation von Blutgerinnungsfaktor VIII enthaltenden Präparaten |
US4568542A (en) * | 1981-06-09 | 1986-02-04 | Lee Biomolecular Research Laboratories, Inc. | Vaccine compositions |
-
1984
- 1984-04-27 DE DE8484302845T patent/DE3483751D1/de not_active Expired - Lifetime
- 1984-04-27 EP EP84302845A patent/EP0124363B1/fr not_active Expired - Lifetime
- 1984-04-27 AT AT84302845T patent/ATE59145T1/de not_active IP Right Cessation
- 1984-04-30 AU AU27521/84A patent/AU563557B2/en not_active Expired
- 1984-05-01 JP JP59086273A patent/JPS6016930A/ja active Granted
- 1984-05-01 CA CA000453232A patent/CA1224622A/fr not_active Expired
- 1984-05-02 ZA ZA843270A patent/ZA843270B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP0124363B1 (fr) | 1990-12-19 |
JPH0572366B2 (fr) | 1993-10-12 |
CA1224622A (fr) | 1987-07-28 |
ATE59145T1 (de) | 1991-01-15 |
EP0124363A3 (en) | 1985-07-03 |
AU563557B2 (en) | 1987-07-16 |
AU2752184A (en) | 1984-11-08 |
JPS6016930A (ja) | 1985-01-28 |
EP0124363A2 (fr) | 1984-11-07 |
DE3483751D1 (de) | 1991-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA843270B (en) | Photochemical decontamination treatment of whole blood or blood components | |
DE10199020I1 (de) | Galanthamin oder dessen Analoge zur Behandlung der Alzheimerschen Krankheit | |
DE68928051T2 (de) | Behandlung von humanem Kollagen und Verwendung als Auto-Implantat | |
ATA380384A (de) | Verwendung von solarfiltern zur stabilisierung und verbesserung der hautvertraeglichkeit von benzoylperoxyd enthaltenden zubereitungen zur lokalen aknebehandlung | |
DE3869230D1 (de) | Verfahren zur herstellung einer loesung hoher spezifischer volumenaktivitaet von einem protein mit gewebe-plasminogenaktivator (t-pa)-aktivitaet, loesung, enthaltend protein mit t-pa-aktivitaet und verwendung der loesung in der human- und veterinaermedizin. | |
DE68910175T2 (de) | Adsorbermodul sowie Adsorberapparat zur Behandlung von Vollblut. | |
NO913129L (no) | Nytt trombolytisk middel. | |
DE58902451D1 (de) | (s)-emopamil zur anwendung bei der behandlung von migraene. | |
AU584548B2 (en) | Sterilization of adsorbent and column having improved storability including sterilized adsorbent for use in extracorporeal circulation treatment | |
ATE25969T1 (de) | 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten. | |
DE3674619D1 (de) | Zusammensetzung fuer baeder auf basis von psoralen in der behandlung von psoriasis. | |
DE3764697D1 (de) | T-pa enthaltende medizinische zubereitung und deren verwendung. | |
NZ220495A (en) | A2a cyclopeptan-2-ones carrier containing methotrexate compositions | |
DE3872871T2 (de) | Verwendung von metalloporphyrin zur umkehr des toxischen effekts der tumortherapie. | |
CA2015315A1 (fr) | Methode de decontamination des composants du sang par addition de glucose et conditionnement sous atmosphere modifiee | |
ATE75938T1 (de) | Enantiomere des propafenons enthaltende therapeutische mittel. | |
ATE136776T1 (de) | Verwendung von heptastigmin zur behandlung der zerebralen ictus | |
HK5495A (en) | New use of 1,4-dihydropyridine derivatives | |
ATE88090T1 (de) | Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom. | |
PH12015A (en) | Method and composition for the treatment of athlete's foo | |
ATE56681T1 (de) | Behandlung geschmeidiger gewebe. | |
ATE65398T1 (de) | Verwendung von oxirancarbonsaeuren zur behandlung der hyperlipaemie. | |
ATE92897T1 (de) | Verfahren zur wasserbehandlung durch die synergie von reaktivierung und kavitation. |